Publicacións (1.036) Publicacións de José Ramón González Juanatey

filter_list

2026

  1. FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide

    Journal of Molecular and Cellular Cardiology, Vol. 210, pp. 12-27

2025

  1. Angina estable

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 43, pp. 2562-2568

  2. Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score

    European heart journal, Vol. 46, Núm. 3, pp. 273-284

  3. Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction

    The New England journal of medicine, Vol. 393, Núm. 19, pp. 1889-1900

  4. Cardiopatía isquémica: Concepto, clasificación, factores de riesgo y prevención

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 43, pp. 2557-2561

  5. Carvedilol versus flecainide treatment in idiopathic ventricular extrasystoles and tachycardias (CARFLECT IV) trial: Rationale and design

    Revista Portuguesa de Cardiologia

  6. Complicaciones mecánicas del infarto agudo de miocardio

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 44, pp. 2618-2620

  7. Continuity of primary care and its impact on prognosis in patients with heart failure referred for cardiology consultation

    BMC Primary Care, Vol. 26, Núm. 1

  8. Coronary sinus unroofing associated with congenitally corrected transposition of the great arteries: a case report

    European Heart Journal - Case Reports, Vol. 9, Núm. 2

  9. Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trial

    The Lancet Regional Health - Europe, Vol. 55

  10. Differential effect of triglycerides on the prognosis of patients with a first versus recurrent acute coronary syndrome

    European Journal of Clinical Investigation, Vol. 55, Núm. 10

  11. Echocardiographic phenotype in severe aortic stenosis with and without transthyretin cardiac amyloidosis: the AMY-TAVI study

    European Heart Journal Cardiovascular Imaging, Vol. 26, Núm. 2, pp. 261-272

  12. Effect of Dapagliflozin on Quality of Life of Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

    Journal of the American College of Cardiology, Vol. 86, Núm. 15, pp. 1128-1138

  13. Effects of GLP-1 agonists on 10-year cardiovascular risk reduction in primary prevention: A 44-week open label prospective study

    Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 19, Núm. 9

  14. Epigenetic regulation of electromechanical continuity might determine phenotypic heterogeneity in SCN5A mutation carriers in Brugada syndrome

    Scientific Reports, Vol. 15, Núm. 1

  15. Estimate and prognosis of patients who are candidates for treatment with eicosapentaenoic acid after an acute coronary syndrome

    Journal of Clinical Lipidology, Vol. 19, Núm. 4, pp. 827-834

  16. Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial

    Circulation: Cardiovascular Quality and Outcomes, Vol. 18, Núm. 3, pp. e010849

  17. Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis

    Heart

  18. Factors Predicting Myocardial Recovery After Hospitalization for De Novo Heart Failure with Reduced Left Ventricular Ejection Fraction: Results from the COMFE Registry

    Biomedicines, Vol. 13, Núm. 5

  19. Formas especiales de cardiopatía isquémica crónica: Síndrome cardíaco X; angina vasoespástica e isquemia silente

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 14, Núm. 43, pp. 2577-2580